Shanghai Junshi Biosciences (Stock Code: 1877, 688180) Announces 2025 Third Quarterly Results Briefing

Bulletin Express
10/21

Shanghai Junshi Biosciences Co., Ltd.* (Junshi Bio) has scheduled its 2025 third quarterly results briefing for 29 October 2025 (Wednesday), from 11:00 to 12:00, at the Shanghai Stock Exchange Roadshow Center. The company will issue its third quarter earnings report on the Shanghai Stock Exchange (www.sse.com.cn) on the same day.

Company representatives plan to discuss recent operating results and financial indicators during the session. Interested investors may submit questions online in advance through the 「Pre-collection of Questions」 section at the SSE Roadshow Center website or via the company’s email (info@junshipharma.com) between 22 October 2025 (Wednesday) and 16:00 on 28 October 2025 (Tuesday). Questions of general interest will be addressed in the scheduled briefing.

Participants from the company are expected to include an executive director, an independent non-executive director, the financial director, and the secretary of the board of directors. Updates from the briefing will be accessible for review on the SSE Roadshow Center website following the event.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10